Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

362.28 5.51 −1.50%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

23.80 23.49 23.01 25.11
P/S ratio
1.50 1.55 1.59 1.71
P/FCF ratio
19.40 17.41 22.16 21.60
P/Operating CF
33.98 114.67 51.35 44.32
P/B ratio
2.42 2.52 2.66 2.82
EV/Sales
1.83 1.90 2.00 2.06
EV/EBITDA
12.34 12.63 13.07 13.61
EV/FCF
23.69 21.31 27.76 25.97
Current Ratio
1.42 1.73 1.80 1.41
Net Debt/EBITDA
15.83 8.87 9.16 6.92
Debt/Equity
0.60 0.68 0.69 0.60
Earnings Yield
4.20% 4.26% 4.35% 3.98%
Free Cash Flow Yield
5.15% 5.74% 4.51% 4.63%
Free Cash Flow per Share
5.99 0.95 3.87 4.96
Book value per Share
103.60 106.06 105.35 109.10
Free Cash Flow
498.30 78.30 315.80 402.50
EV/EBIT
18.41 18.67 19.15 20.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026